Genzyme Synvisc OA Therapy Boosts Margins, Holds Promise For New Claims
Genzyme is exploring Synvisc ankle, shoulder, hip osteoarthritis indications while ramping up its newly acquired sales force for hyaluronic acid viscosupplementation therapy.
Genzyme is exploring Synvisc ankle, shoulder, hip osteoarthritis indications while ramping up its newly acquired sales force for hyaluronic acid viscosupplementation therapy.